SIG
CELG

Stanford Investment Group’s Celgene Corp CELG Stock Holding History

Stanford Investment Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,364
Closed -$158K – 360
2016
Q4 		$158K Buy
1,364
+68
+5% +$7.57K 0.08% 61
2016
Q3 		$135K Buy
1,296
+500
+63% +$54.1K 0.06% 78
2016
Q2 		$79K Hold
796
– – 0.04% 107
2016
Q1 		$80K Buy
796
+400
+101% +$41.2K 0.05% 102
2015
Q4 		$47K Hold
396
– – 0.03% 131
2015
Q3 		$43K Hold
396
– – 0.03% 128
2015
Q2 		$46K Hold
396
– – 0.03% 133
2015
Q1 		$46K Sell
396
-80
-17% -$9.56K 0.04% 140
2014
Q4 		$53K Buy
+476
New +$50.2K 0.04% 130

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stanford Investment Group's CELG Position: Q1 2017 in Review

Stanford Investment Group sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 1,364 shares — an estimated $158K sold.

Stanford Investment Group first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $158K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • Stanford Investment Group reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 1,364 Celgene Corp shares in Q1 2017, an estimated $158K.
  • Stanford Investment Group first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Celgene Corp position peaked at $158K in Q4 2016.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.